Company Profile

SHREE GANESH REMEDIES LTD.

NSE : NABSE : 540737ISIN CODE : INE414Y01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE410.255.4 (+1.33 % )
PREV CLOSE (Rs.) 404.85
OPEN PRICE (Rs.) 405.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 6483
TODAY'S LOW / HIGH (Rs.)395.15 420.00
52 WK LOW / HIGH (Rs.) 118.95 502.95
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.37
TTM EPS (Rs.) 9.75
P/E Ratio 42.09
Book Value (Rs.) 52.31
Face Value (Rs.) 10
MCap (Rs. in Mn) 4105.14
Price/Earning (TTM) 32.90
Price/Sales (TTM) 8.36
Price/Book (MRQ) 7.84
PAT Margin (%) 16.47
ROCE (%) 32.63
Incorporation Year : 1995

Management Info :

- Chairman Chandulal Manubhai Kothia - Managing Director

Registered Office :

Address : Plot No. 6011,G I D C, ,
Ankleshwar,
Gujarat-393002

Phone : 02641 22777

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
16Oct10-16-2021$Shree Ganesh Remedies fixes record date for issue of bonus equity shares Shree Ganesh Remedies fixes

Shree Ganesh Remedies has informed that pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Tuesday, November 2, 2021 as the Record Date, for the purpose of ascertaining the eligibility of shareholders entitled for issuance of Bonus Equity Shares in the proportion of 1 (One) Equity Shares of Rs 10 each for every 5 (Five) existing Equity Shares of Rs 10 each, subject to the approval of shareholders which is being obtained through postal ballot.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remedies has informed that pursuant to Regulation..
09Sep09-09-2021$Shree Ganesh Remedies shines on acquiring entire stake in Akshar Jyot Shree Ganesh Remedies shines

Shree Ganesh Remedies is currently trading at Rs. 391.70, up by 7.00 points or 1.82% from its previous closing of Rs. 384.70 on the BSE.

The scrip opened at Rs. 394.80 and has touched a high and low of Rs. 414.00 and Rs. 382.15 respectively. So far 12231 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 461.40 on 18-Jun-2021 and a 52 week low of Rs. 110.28 on 09-Sep-2020.

Last one week high and low of the scrip stood at Rs. 425.00 and Rs. 345.60 respectively. The current market cap of the company is Rs. 391.25 crore.

The promoters holding in the company stood at 68.39% and Non-Institutions held 31.61%.

Shree Ganesh Remedies has acquired 100% equity stake of Akshar Jyot (AJPL). AJPL was incorporated to carry on the business of manufacturing of pharmaceuticals intermediates, medicinal preparations and its related articles and products.

Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.

Shree Ganesh Remedies is currently trading at Rs. 391.70, up by..
09Sep09-09-2021$TCS, Infosys and Cigniti Technologies to see some action today TCS, Infosys and Cigniti Tec

Tata Consultancy Services (TCS) has been selected by Avianca, one of the leading airlines in South America, as a strategic partner in its cloud transformation journey. TCS will modernize Avianca's IT infrastructure and build a new future-ready cloud-based digital core on Microsoft Azure. Leveraging its deep domain knowledge of the airline industry and its extensive experience in successfully executing large transformation programs, TCS will help the airline migrate 129 core applications to the cloud and will also manage the new cloud estate.

Infosys and The Economist Group have designed new strategic partnership to enable and accelerate sustainability solutions and drive world-changing impact through a new business-to-business model. This initiative is designed to unlock the long-term thinking of businesses and other institutions, combining insights, innovation and influence, to address the most challenging sustainability issues facing our planet today. This aspiration has driven Infosys and The Economist Group to join forces to create the necessary climate for change.

Cigniti Technologies has opened their office in Prague, Czech Republic. With this new expansion, Cigniti further extends its global footprint in the European region to meet the growing digital transformation needs of leading enterprises based in the region. Cigniti is currently serving enterprises from eight countries in the Europe and the U.K.

In its endeavour to completely pay off its overseas debt, Jindal Steel & Power (JSPL) through its step down subsidiary, Jindal Steel & Power (Australia), made a pre-payment of $105.66 million (approximately Rs 777.4 crores). The prepayment has helped reduce the Australian debt by approx. 50%. The company's Net Debt/EBITDA on Consolidated basis was reported at 0.96x while Standalone Net Debt/EBITDA was approx. 0.7x as of June quarter which is expected to go down further this quarter.

Adani Power’s wholly owned subsidiary company -- Adani Power Maharashtra (APML) has been declared as successful bidder for commercial mining of Gondkhari coal block in Maharashtra.

Shree Ganesh Remedies has acquired 100% equity stake of Akshar Jyot (AJPL). AJPL was incorporated to carry on the business of manufacturing of pharmaceuticals intermediates, medicinal preparations and its related articles and products.

Reliance Industries’ subsidiary -- Reliance Retail has become the second-largest customer of the Kishore Biyani-led Future group's FMCG arm Future Consumer, contributing over one-fourth of the total sales of the company. In the financial year 2020-21, the retail arm of Reliance Industries has purchased goods worth Rs 157.54 crore from Future Consumer, accounting 26.8 per cent of the total sales of Rs 586.15 crore.

Tata Consultancy Services (TCS) has been selected by Avianca, o..
09Sep09-09-2021$ Announcement under Regulation 30 (LODR)-Acquisition Announcement under Regulati
Acquisition of 100% equity stake of Akshar Jyot Private Limited.
Acquisition of 100% equity stake of Akshar Jyot Private Limited.
08Sep09-08-2021$Shree Ganesh Remedies acquires entire stake in Akshar Jyot Shree Ganesh Remedies acquir

Shree Ganesh Remedies has acquired 100% equity stake of Akshar Jyot (AJPL). AJPL was incorporated to carry on the business of manufacturing of pharmaceuticals intermediates, medicinal preparations and its related articles and products.

Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.

Shree Ganesh Remedies has acquired 100% equity stake of Akshar..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit23.3797.5299999999999
Gross Profit 32.78 129.49
Operating Profit 41.63157.42
Net Sales 126.33490.82
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 20746.95 (0.93%)
M.Cap ( in Cr)
44085.82
Ajanta Pharma (BSE)
 2215.40 (2.45%)
M.Cap ( in Cr)
19171.13
Sanofi India (BSE)
 8117.95 (0.35%)
M.Cap ( in Cr)
18696.14
Mercury Laboratories (BSE)
 718.00 (3.16%)
M.Cap ( in Cr)
86.16
Suven Pharma (BSE)
 533.95 (1.75%)
M.Cap ( in Cr)
13592.50
Shareholding Pattern More
PROMOTERS 69.12 %
NON-INSTITUTION 30.88 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes